Skip to main content
All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Nonprofit supporting patients with inheritable bleeding disorders.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 6
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 864
    HELP Copays Act
  • HR 6423
    HELP Copays Act
  • HR 247
    Health Care Affordability Act of 2025
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions …
  • HR 1834
    Breaking the Gridlock Act
 Lobbying activity 6
Medicare/Medicaid

H.R. 1, One Big Beautiful Bill Act Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid

Health Issues

Blood and plasma safety and awareness Bleeding disorders awareness

Insurance

H.R. 1, One Big Beautiful Bill Act Implementation of the Affordable Care Act The HELP Copays Act (S. 864, H.R. 6423) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to the extension of enhanced advanced premium tax credits, including HR 247, HR 1, HR 5371, S 46, HR 1834. Protect patients from substandard and junk insurance products

Budget/Appropriations

Funding for federal hemophilia programs in FY26 House and Senate Labor-HHS Appropriations bills NIH FY26 appropriations

Pharmacy

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Medical/Disease Research/Clinical Labs

Hemophilia research, prevention, surveillance and service programs and issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem